Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-29

FDA Approved: REXTOVY — Supplemental Application (International Medication Systems, Ltd.)

View source ↗

Summary

The FDA approved a supplemental application for REXTOVY (naloxone hydrochloride) filed by International Medication Systems, Ltd. The action represents an approv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • REXTOVY (Naloxone hydrochloride)

Snippet

SUPPL AP for REXTOVY (NALOXONE HYDROCHLORIDE)